Effect of Quyu Huatan Decoction on Polycystic Change, Endocrine and Metabolism in Patients with Polycystic Ovary Syndrome

HUA Cai-hong; YIN Shan-lan; HAO Shang-hui; ZHAO Shu-zhen; ZHU Li-hong; SHEN Su-fang

doi:10.13422/j.cnki.syfjx.2017090179

您当前的位置：

首页 >

文章列表页 >

Effect of Quyu Huatan Decoction on Polycystic Change, Endocrine and Metabolism in Patients with Polycystic Ovary Syndrome

更新时间：2024-01-04

- Effect of Quyu Huatan Decoction on Polycystic Change, Endocrine and Metabolism in Patients with Polycystic Ovary Syndrome
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 23, Issue 9, Pages: 179-183(2017)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2017090179
  CLC： R285.6
- Published：2017
- 稿件说明：
移动端阅览
HUA Cai-hong, YIN Shan-lan, HAO Shang-hui, et al. Effect of Quyu Huatan Decoction on Polycystic Change, Endocrine and Metabolism in Patients with Polycystic Ovary Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(9): 179-183.
DOI：

HUA Cai-hong, YIN Shan-lan, HAO Shang-hui, et al. Effect of Quyu Huatan Decoction on Polycystic Change, Endocrine and Metabolism in Patients with Polycystic Ovary Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(9): 179-183. DOI： 10.13422/j.cnki.syfjx.2017090179.

摘要

目的：探讨祛瘀化痰汤对多囊卵巢综合征患者卵巢多囊样改变、内分泌及代谢的影响，并探讨其作用机制。方法：选取新乡医学院第一附属医院妇产科符合纳入标准的92例多囊卵巢综合征患者，按随机数字表法分为对照组和观察组，各46例，对照组予以炔雌醇环丙孕酮，1片/d，观察组在常规治疗基础上联用祛瘀化痰汤治疗，共治疗3个月经周期，测定血清学指标，记录卵巢多囊样改变，同时对比临床疗效。结果：与治疗前比较，两组患者治疗后促卵泡生成素（FSH），黄体生成素（LH）和睾酮（T）含量降低，雌二醇（E2）含量升高，糖脂代谢指标降低，内脂素（VF），瘦素（LEP）含量降低，脂联素（APN）含量升高，卵巢体积和卵巢内卵泡数量明显降低（P<0.05）；与对照组比较，观察组治疗后FSH，LH和T含量较低，E2含量较高，糖脂代谢指标较低，VF，LEP含量较低，APN含量较高，卵巢体积和卵巢内卵泡数量明显降低（P<0.05）；对照组有效率（73.91%）明显低于观察组（91.31%）（P<0.05）。结论：祛瘀化痰汤治疗多囊卵巢综合征疗效确切，可改善卵巢多囊样改变、内分泌及代谢功能。

Abstract

Objective: To investigate the effect of Quyu Huatan decoction on ovary polycystic change

endocrine and metabolism in patients with polycystic ovary syndrome

and explore its action mechanism. Method: The 92 patients who met the inclusion criteria in the department of endocrinology in our hospital were selected and randomly divided into 2 group

46 cases in control group and 46 cases in observation group. Patients in control group were treated with ethinylestradiol and cyproterone acetate

1 tablet a day

and patients in treatment group received Quyu Huatan decoction based on the treatment in control group. All patients were treated for 3 menstrual cycles

and then their serological index

polycystic ovarian changes

and clinical efficacy were compared after the treatment. Result: After treatment

the levels of follicle-stimulating hormone (FSH)

luteinizing hormone (LH) and testosterone (T) were decreased

levels of estradiol (E2) were increased

levels of glucose and lipid metabolism indexes were decreased; levels of visfatin (VF)

leptin (LEP) were decreased

levels of adiponectin (APN) were increased

and the number of ovarian follicles and ovarian volume were decreased in both groups (P<0.05). As compared with control group

levels of FSH

LH and T were lower

levels of E2 were higher

levels of glucose and lipid metabolism indexes were lower

levels of VF

LEP were lower

levels of APN were higher

and the number of ovarian follicles and ovarian volume were lower in treatment group after treatment (P<0.05). The effective rate in control group (73.91%) was significantly lower than that in observation group (91.31%) (P<0.05). Conclusion: Quyu Huatan decoction had clear clinical efficacy in the treatment of polycystic ovary syndrome

and it can improve ovary polycystic changes

endocrine and metabolic function.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanism of Kidney-tonifying and Liver-regulating Cyclical Therapy and Formula in Improving Endometrial Receptivity during "Implantation Window" in Rats with Polycystic Ovary Syndrome via miR-140-5p/VEGF Pathway

Mechanism of Modified Guishenwan in Regulating AMPK/Akt/Nrf2 Pathway to Improve Glucose and Lipid Metabolism and Oxidative Stress in Polycystic Ovary Syndrome Rats

Modified Guishenwan Alleviates Inflammation in Rat Model of Polycystic Ovary Syndrome by Inhibiting MAPK/NF-κB Pathway

Signaling Pathways Related to Polycystic Ovary Syndrome and Regulation by Traditional Chinese Medicine： A Review

Professor LIU Minru's Medication Rule in Treatment of Polycystic Ovary Syndrome （Intracellular Lipid Membrane Congestion Syndrome）

Related Author

LIU Quan

HE Yiqing

ZHANG Ying

WANG Xi

YANG Shuo

TIAN Jiayu

QIN Wenyi

YANG Juan

Related Institution

Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases， Hunan University of Chinese Medicine

Hunan University of Chinese Medicine

The First Affiliated Hospital of Chongqing Medical University

The Third Affiliated Hospital of Henan University of Chinese Medicine

Henan University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰